Veracyte
VCYT
240 hedge funds and large institutions have $1.78B invested in Veracyte in 2024 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 90 increasing their positions, 85 reducing their positions, and 29 closing their positions.
132% more call options, than puts
Call options by funds: $966K | Put options by funds: $417K
6% more repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 85
2% less capital invested
Capital invested by funds: $1.82B → $1.78B (-$38.1M)
1.9% less ownership
Funds ownership: 109.34% → 107.44% (-1.9%)
2% less funds holding
Funds holding: 246 → 240 (-6)
10% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 29
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
ECM
ExodusPoint Capital Management
New York
|
+$13.7M |
| 2 |
BlackRock
New York
|
+$12.2M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$11.9M |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
+$10.5M |
| 5 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$9.88M |
Top Sellers
VCYT Hedge Fund Activity: Q2 2024 in Review
240 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q2 2024, worth a combined $1.78B — down 2.1% from $1.82B a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of VCYT and 26 opened new positions — a net loss of 3 holders — while 85 trimmed existing stakes and 90 added.
The largest buyer was ExodusPoint Capital Management, adding an estimated $13.7M. The largest seller was State Street, cutting an estimated $29.8M.
- 240 institutional investors held Veracyte (VCYT) as of Q2 2024, down from 246 in Q1 2024.
- Funds reported $1.78B of Veracyte stock for Q2 2024, down 2.1% quarter-over-quarter.
- 26 funds opened new Veracyte positions in Q2 2024 and 29 closed out, a net change of -3 holders.
- The largest Veracyte buyer in Q2 2024 was ExodusPoint Capital Management, an estimated $13.7M added.
- The largest Veracyte seller in Q2 2024 was State Street, an estimated $29.8M sold.
Based on aggregated 13F filings for Q2 2024.